Sky News

‘King Kong’ weight loss drug to be given to less than 10% of eligible people in first rollout

Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey




Less than 10% of the millions eligible for the so-called « King Kong of weight loss drugs » will be able to get it in the next three years, according to guidance by the National Institute for Health and Care Excellence (NICE).



Source link : https://news.sky.com/story/king-kong-weight-loss-drug-to-be-given-to-less-than-10-of-eligible-people-in-first-rollout-13266788

Author :

Publish date : 2024-12-04 14:30:00

Copyright for syndicated content belongs to the linked Source.

Tags :Sky News
Quitter la version mobile